Showing results (21-30 of 180) with videos related to
Sort By:
Pageof 18
Cancer Research|August 28, 2010
Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatinKedar Hastak, Elizabeth Alli, James M FordScientific Reports|October 21, 2025
PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cellsSamyuktha Suresh, Lisa McPherson, James M FordCancer Letters|November 13, 2013
Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cellsLisa A McPherson, Yuqiao Shen, James M FordOncotarget|April 17, 2017
Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancersKedar Hastak, Steven Bhutra, Renate Parry, et al.Cancer|September 19, 2008
Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgeryRobin M Cisco, James M Ford, Jeffrey A NortonCurrent Opinion in Obstetrics & Gynecology|December 16, 2014
Next-generation sequencing for hereditary breast and gynecologic cancer risk assessmentAllison W Kurian, Kerry E Kingham, James M FordCarcinogenesis|May 29, 2003
p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivoMaureen E Fitch, Irina V Cross, James M FordMutation Research|December 4, 2003
Functional characterization of global genomic DNA repair and its implications for cancerPhilip C Hanawalt, James M Ford, Daniel R LloydCancer Treatment Reviews|March 1, 2016
DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applicationsIris H Liu, James M Ford, Pamela L KunzThe Journal of Biological Chemistry|August 29, 2003
In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene productMaureen E Fitch, Satoshi Nakajima, Akira Yasui, et al.Pageof 18